BioSpace News Archive

Program focuses on personalized solutions for hip, knee, spine and shoulder arthroplasty and arthroscopy

Now offers “tube-up” design options for nasal and nasal pillows mask wearers, providing even more flexibility and choice to help users sleep better in any position

Oncopeptides AB announced that it has updated its financial calendar, the interim report for Q2 2019 have been moved to 28 August.

Officials from Health Canada will hold a technical briefing to discuss the final re-evaluations of the neonicotinoid pesticides clothianidin, imidacloprid and thiamethoxam.

Alpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced that it has obtained ISO 13485:2016 certification.

LumiThera Inc. announced it has begun enrolling patients in a European Union multi-center clinical study in dry Age-Related Macular Degeneration patients.

EQUELLE, a new non-prescription, non-hormonali supplement clinically shown to alleviate the frequency of hot flashes and muscle aches associated with menopause†, has launched.

New LIFEPAK AED Response System Offers Connectivity, Intuitive Design and Unique Technology to Analyze Heart Rhythm during CPR [11-April-2019] REDMOND, Wash. , USA, April 11, 2019 /PRNewswire/ -- Stryker has launched the company’s newest defibrillation solution, the LIFEPAK ® CR2 defibrillator with LIFELINKcentral™ AED program manager, in the United States . The c

Company brings together world-recognized leaders in immunobiology, cancer biology, and clinical and translational medicine

Pandion Therapeutics is a biotechnology platform company developing therapeutics to achieve localized immunomodulation to treat autoimmune and inflammatory disease.